Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus.
Pei-Fong WongIrina Isakova-SivakEkaterina StepanovaElena KrutikovaEkaterina A BazhenovaAndrey RekstinLarisa RudenkoPublished in: Vaccines (2024)
The new RG system for B60 MDV allowed the rapid generation of type B LAIV reassortants with desired genome compositions. The generation of hybrid LAIV reassortants with HA and NA genes belonging to the opposite IBV lineages is a promising approach for the development of IBV vaccines with broad cross-protection.